FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nigel Rawson

Research Profile

Geographic Areas

Activities & Behaviors

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nigel Rawson; Jorge A Ross Terres
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010.
Nigel Rawson; Rong Chu; Afisi S Ismaila; Jorge Alfonso Ross Terres
The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020.
Nigel Rawson
Commentary: Canadian Association for Population Therapeutics: the past, present and future - a personal viewpoint and a call to action.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nigel Rawson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nigel Rawson; Jorge A Ross Terres
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010.
BMC research notes 2013;6():82.
2012: Nigel Rawson; Rong Chu; Afisi S Ismaila; Jorge Alfonso Ross Terres
The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020.
BMC cardiovascular disorders 2012;12():25.
2011: Nigel Rawson
Commentary: Canadian Association for Population Therapeutics: the past, present and future - a personal viewpoint and a call to action.
Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique 2011;18(2):e403-6.
2011: Nigel Rawson; Winanne Downey; Colleen J Maxwell; Roy West
25 years of pharmacoepidemiologic innovation: the Saskatchewan health administrative databases.
Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique 2011;18(2):e245-9.
2010: Nigel Rawson; Fred Saad
The aging male population and medical care for benign prostatic hyperplasia in Canada.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2010;4(2):123-7.
2009: Nigel Rawson
Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example.
Pharmacoepidemiology and drug safety 2009;18(11):1072-9.
2008: Andrea C Tricco; Ba' Pham; Nigel Rawson
Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions.
Journal of clinical epidemiology 2008;61(2):192-197.
2007: Jacques LeLorier; Nigel Rawson
Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.
The Canadian journal of cardiology 2007;23(9):711-8.
2007: Susan S Huang; James M Livingston; Nigel Rawson; Stephen Schmaltz; Richard Platt
Developing algorithms for healthcare insurers to systematically monitor surgical site infection rates.
BMC medical research methodology 2007;7():20.
2006: Nigel Rawson; Leanne R De Souza
Epidemiology in the pharmaceutical Industry: A Canadian perspective.
Pharmacoepidemiology and drug safety 2006;15(10):758-62.
2006: Deborah Shatin; Nigel Rawson; Jeffrey R Curtis; M Miles Braun; Carolyn K Martin; Larry W Moreland; Angela F Becker; Nivedita M Patkar; Jeroan J Allison; Kenneth G Saag
Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions.
Pharmacoepidemiology and drug safety 2006;15(1):11-8.
2005: Nigel Rawson
Assessing prescription medications for priority regulatory review.
Regulatory toxicology and pharmacology : RTP 2005;42(1):70-6.
2005: Nigel Rawson; Parivash Nourjah; Stella C Grosser; David J Graham
Factors associated with celecoxib and rofecoxib utilization.
The Annals of pharmacotherapy 2005;39(4):597-602.
2004: Nigel Rawson
Rx: Canadian drugs.
The New England journal of medicine 2004;350(11):1155.
2003: Nigel Rawson; Kenneth I Kaitin
Canadian and US drug approval times and safety considerations.
The Annals of pharmacotherapy 2003;37(10):1403-8.
2003: Roy West; E Keith Borden; Jean-Paul Collet; Nigel Rawson; Robert S Tonks
A national drug agency.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(8):962-3.
2003: Nigel Rawson
Timeliness of review and approval of new drugs in Canada from 1999 through 2001: is progress being made?
Clinical therapeutics 2003;25(4):1230-47.
2003: Roy West; E Keith Borden; Jean-Paul Collet; Nigel Rawson; Robert S Tonks
Need for an improved submission process for listing drugs for reimbursement in Canadian provinces.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2003;10(4):207-10.
2003: Nigel Rawson
Letter to the ISPE commentary editor.
Pharmacoepidemiology and drug safety 2003;12(1):71-2.
2002: Roy West; E Keith Borden; Jean-Paul Collet; Nigel Rawson; Robert S Tonks
"Cost-effectiveness" estimates result in flawed decision-making in listing drugs for reimbursement.
Canadian journal of public health. Revue canadienne de santé publique 2002;93(6):421-5.
2002: Nigel Rawson
Issues in the approval of, access to, and post-marketing follow-up of new drugs in Canada: a personal viewpoint.
Pharmacoepidemiology and drug safety 2002;11(4):335-40; discussion 341-2.
2002: Nigel Rawson
Human resources for the approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2002;9(2):73-8.
2002: Nigel Rawson; Jafna L Cox; MaryRose Stang; Maureen J Rawson
New use of antiarrhythmia drugs in Saskatchewan.
The Canadian journal of cardiology 2002;18(1):43-50.
2001: Nigel Rawson
Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data.
Pharmacoepidemiology and drug safety 2001;10(7):607-12.
2001: Nigel Rawson
"Effectiveness" in the evaluation of new drugs: a misunderstood concept?
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2001;8(2):61-2.
2000: Nigel Rawson; D L Robson
Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.
Canadian journal of public health. Revue canadienne de santé publique 2000;91(5):390-3.
2000: Nigel Rawson
Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(4):501-4.
2000: Nigel Rawson; Roy West; W C Appel
Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2000;7(4):185-90.
2000: Nigel Rawson; Kenneth I Kaitin
New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2000;7(2):97-101.
1999: Nigel Rawson; Maureen J Rawson
Acute adverse event signalling scheme using the Saskatchewan Administrative health care utilization datafiles: results for two benzodiazepines.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 1999;6(3):159-66.
1998: Nigel Rawson; SR Harding; E Malcolm; L Lueck
Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
Journal of clinical epidemiology 1998;51(12):1343-55.
1998: Nigel Rawson; Carl D'Arcy
Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan.
Pharmacoepidemiology and drug safety 1998;7(6):389-98.
1997: Nigel Rawson; E Malcolm; Carl D'Arcy
Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles.
Social psychiatry and psychiatric epidemiology 1997;32(4):191-9.
1997: Margaret Crossley; Carl D'Arcy; Nigel Rawson
Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with dementia of the Alzheimer or vascular type.
Journal of clinical and experimental neuropsychology 1997;19(1):52-62.
1996: Lindsay Edouard; Nigel Rawson
Reliability of the recording of hysterectomy in the Saskatchewan health care system.
British journal of obstetrics and gynaecology 1996;103(9):891-7.
1995: Nigel Rawson; E Malcolm
Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles.
Statistics in medicine 1995;14(24):2627-43.
1995: Nigel Rawson
Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.
The Annals of pharmacotherapy 1995;29(7-8):676-80.
1995: A Jameel; R Stein; Nigel Rawson; A Hedley; J Stuttaford; R Coombes
Comparative-study of intramuscular ketorolac tromethamine and morphine in patients experiencing cancer pain.
International journal of oncology 1995;6(6):1307-11.
1995: Lindsay Edouard; Nigel Rawson
Use of personal records for research purposes. Identification numbers help maintain confidentiality.
BMJ (Clinical research ed.) 1995;310(6974):257-8.
1995: Nigel Rawson
The timeliness of new drug approvals in Canada.
International journal of health services : planning, administration, evaluation 1995;25(1):153-65; discussion 167-71.
1994: Lindsay Edouard; Nigel Rawson
Cutting costs by targeting prescribing practices.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1994;151(1):14-5.
1994: Lindsay Edouard; Nigel Rawson
Unlocking datasets.
Lancet 1994;343(8889):118.
1992: D Ricketts; L Hadcocks; M Fitzek; Nigel Rawson; K Colston; T J Powles; J C Gazet; R Charles Coombes
Serum markers for primary and recurrent breast cancer: BCM-EIA, CAM 26 and CAM 29.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1992;13(4):207-16.
1991: Nigel Rawson
Plus ça change, plus c'est la même chose.
Journal of public health medicine 1991;13(4):342.
1991: C Topham; J Glees; Nigel Rawson; E M Woods; R C Coombes
Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
British journal of cancer 1991;64(1):179-81.
1991: D Ricketts; L Turnbull; G Ryall; R Bakhshi; Nigel Rawson; J C Gazet; C Nolan; R Charles Coombes
Estrogen and progesterone receptors in the normal female breast.
Cancer research 1991;51(7):1817-22.
1991: J G Edwards; W H Inman; GL Pearce; Nigel Rawson
Prescription-event monitoring of 10,895 patients treated with alprazolam.
The British journal of psychiatry : the journal of mental science 1991;158():387-92.
1991: Nigel Rawson; Carl D'Arcy
Sedative-hypnotic drug use in Canada.
Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la santé / Statistique Canada, Centre canadien d'information sur la santé 1991;3(1):33-57.
1990: W F Hendry; Nigel Rawson; L Turney; A Dunlop; H N Whitfield
Computerisation of urothelial carcinoma records: 16 years' experience with the TNM system.
British journal of urology 1990;65(6):583-8.
1990: P M Stell; Nigel Rawson
Adjuvant chemotherapy in head and neck cancer.
British journal of cancer 1990;61(5):779-87.
1990: Nigel Rawson; Julian Peto
An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
British journal of cancer 1990;61(4):597-604.
1990: Nigel Rawson; GL Pearce; W H Inman
Prescription-event monitoring: methodology and recent progress.
Journal of clinical epidemiology 1990;43(5):509-22.
1988: C J Speirs; C T Dollery; W H Inman; Nigel Rawson; Lynda V Wilton
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.
BMJ (Clinical research ed.) 1988;297(6652):830-2.
1988: W H Inman; Nigel Rawson; Lynda V Wilton; GL Pearce; C J Speirs
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.
BMJ (Clinical research ed.) 1988;297(6652):826-9.
1987: W H Inman; Nigel Rawson
Deafness with enalapril and prescription event monitoring.
Lancet 1987;1(8537):872.
1987: W H Inman; Nigel Rawson
Adverse reaction monitoring using cohort identification.
British medical journal (Clinical research ed.) 1987;294(6576):902.
1986: Nigel Rawson; W H Inman
Prescription-Event Monitoring. Recent experience with 5 NSAIDs.
Medical toxicology 1986;1 Suppl 1():79-82.
1985: M H Bellman; Nigel Rawson; J Wadsworth; E M Ross; S Cameron; D L Miller
A developmental test based on the STYCAR sequences used in the National Childhood Encephalopathy Study.
Child: care, health and development 1985;11(5):309-23.
1985: W H Inman; Nigel Rawson
Peptic ulcer and piroxicam.
British medical journal (Clinical research ed.) 1985;290(6472):932-3.
1984: W H Inman; Nigel Rawson
Side-effects of benoxaprofen.
Lancet 1984;2(8415):1336.
1983: W H Inman; Nigel Rawson
Zomepirac and cardiovascular deaths.
Lancet 1983;2(8355):908.
1983: W H Inman; Nigel Rawson
Erythromycin estolate and jaundice.
British medical journal (Clinical research ed.) 1983;286(6382):1954-5.
1981: D L Miller; E M Ross; R Alderslade; M H Bellman; Nigel Rawson
Pertussis immunisation and serious acute neurological illness in children.
British medical journal (Clinical research ed.) 1981;282(6276):1595-9.
1980: Nigel Rawson; R Alderslade; D L Miller
Discrepancies in immunization records.
Community medicine 1980;2(3):202-8.
1979: V Berridge; Nigel Rawson
Opiate use and legislative control: a nineteenth century case study.
Social science & medicine 1979;13A(3):351-63.
1979: G K Litman; J R Eiser; Nigel Rawson; A N Oppenheim
Differences in relapse precipitants and coping behaviour between alcohol relapsers and survivors.
Behaviour research and therapy 1979;17(2):89-94.
1978: A H Ghodse; Nigel Rawson
Distribution of drug-related problems among London casualty departments.
The British journal of psychiatry : the journal of mental science 1978;132():467-72.
1977: G K Litman; J R Eiser; Nigel Rawson; A N Oppenheim
Towards a typology of relapse: a preliminary report.
Drug and alcohol dependence 1977;2(3):157-62.